Kezar Life Sciences Inc
(KZR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 11,551 | 9,853 | 10,478 | 9,997 | 9,681 |
| Operating Income | -11,551 | -9,853 | -10,478 | -9,997 | -9,681 |
| Other Income | 262 | 353 | 466 | 418 | 533 |
| Pre-tax Income | -11,289 | -9,500 | -10,012 | -9,579 | -9,148 |
| Net Income Continuous | -11,289 | -9,500 | -10,012 | -9,579 | -9,148 |
| Net Income | $-11,289 | $-9,500 | $-10,012 | $-9,579 | $-9,148 |
| EPS Basic Total Ops | -2.30 | -2.20 | -3.00 | -5.00 | -4.80 |
| EPS Basic Continuous Ops | -2.26 | -2.21 | -3.05 | -5.01 | -4.79 |
| EPS Diluted Total Ops | -2.30 | -2.20 | -3.00 | -5.00 | -4.80 |
| EPS Diluted Continuous Ops | -2.26 | -2.21 | -3.05 | -5.01 | -4.79 |
| EBITDA(a) | $-11,014 | $-9,571 | $-10,212 | $-9,740 | $-9,549 |